PPIA and breast cancer: Researchers have found that NIM811 and SCY-635 can inhibit hepatocarcinogenesis by disrupting CypA/NS5A interaction in HCV-induced HCC.22 Recent studies have shown that Debio-025 has antitumor and antimetastatic efficacy by suppressing the Crk signaling pathway in breast cancer.